Long-Term Durability of Acoramidis Efficacy in Transthyretin Amyloid Cardiomyopathy Open-Label Extension of the ATTRibute-CM Randomized Clinical Trial

Mar 30, 2026

News

Correlation between neuropathy severity and neurofilament light chain levels in Brazilian patients with hereditary transthyretin amyloidosis

Apr 14, 2026

Amvuttra effective in East Asian patients with hATTR-PN: Trial data

Apr 13, 2026

FDA clears new AI model for detecting signs of cardiac amyloidosis

Apr 10, 2026

FDA Clears First AI Algorithm to Diagnose Cardiac Amyloidosis

Apr 10, 2026

Anumana Receives First and Only FDA Clearance for ECG-AI Cardiac Amyloidosis Algorithm Using a Standard 12-Lead ECG

Apr 08, 2026

More in News

Education

The Future of ATTR-CM Treatment

Apr 15, 2026

Beyond the valve: The long shadow of transthyretin amyloidosis in aortic stenosis

Apr 15, 2026

Cardiac Amyloidosis and Its Impact on the Heart

Mar 25, 2026

What Is Cardiac Amyloidosis and How Does It Affect Heart Function?

Mar 16, 2026

Cardiac phenotype in hereditary transthyretin amyloidosis: correlations between fibril types and 99mTc-DPD uptake

Mar 16, 2026

More in Education

Community Center

Cardiac Amyloidosis: A Hidden Cause of Heart Failure Is Now Treatable

Apr 15, 2026

Amyloidosis Awareness

Apr 14, 2026

Amyloidosis Awareness

Apr 14, 2026

Dr. André discusses Cardiac Amyloidosis, a rare heart disease.

Apr 09, 2026

The one cause of heart failure that still gets missed too-often.

Apr 06, 2026

More in Community Center

Video